Evofem Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Evofem Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
  • Evofem Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $219K, a 18.3% decline year-over-year.
  • Evofem Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $960K, a 48.1% decline year-over-year.
  • Evofem Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.19M, a 64.1% decline from 2022.
  • Evofem Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.31M, a 62.8% decline from 2021.
  • Evofem Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.9M, a 29.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.19M -$2.12M -64.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $3.31M -$5.59M -62.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $8.9M -$3.8M -29.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-27
2020 $12.7M +$4.12M +48% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $8.58M -$9.26M -51.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $17.8M +$17M +1972% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $861K -$570K -39.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 $1.43M +$46.2K +3.34% Jan 1, 2016 Dec 31, 2016 8-K/A 2018-04-06
2015 $1.38M +$772K +126% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $613K +$532K +662% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-23
2013 $80.5K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.